Clinical Trials
3 trialsNCT04145297 2024-11-18
UTAH
University of Utah
Phase 1 Completed
NCT01781429 2020-03-20
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies
BioMed Valley Discoveries, Inc
Phase 1/2 Completed
NCT02296242 2019-01-29
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes
BioMed Valley Discoveries, Inc
Phase 1/2 Completed